Dalteparin Sodium Market

Global Dalteparin Sodium Market Size, Share & Trends Analysis Report, by Type (Tablet, Injection),By Application (Myocardial Infraction Treatment, Hemodialysis, others), Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2024294 | Category : Pharmaceuticals | Delivery Format: /

The Global Dalteparin Sodium Market is estimated to grow at a CAGR of XX% during the forecast period. Dalteparin is a drug that is used to treat and prevent dangerous blood clots. Preventing dangerous blood clots can help you avoid a stroke or heart attack. Dalteparin helps in the smooth flow of blood, by reducing the activity of clotting proteins in the blood. It is commonly known as blood thinner which is  heparin derivative that act as a coagulant. Procedures such as hip replacement or abdominal surgery, long periods of immobility, cert5ain types of heart attacks and type of chest pain, or unstable angina are all raising the chance of dev eloping blood clotsAlthough the kidneys remove heparins, investigations have shown that dalteparin does not accumulate even when renal function is decreased. According to animal studies, over 70% of dalteparin is eliminated through the kidneys.

The global market for dalteparin sodium is expanding, due to the rising prevalence of chronic disorders. Stringent regulations, as well as a scarcity of trained staff with solid technical knowledge, are expected to limit market growth over the projection period. Furthermore, the market for dalteparin sodium is expected to grow due to an increase in government initiatives to improve health-care facilities, a focus on research, and increased research funding

For Instance, In May 2019, approved dalteparin sodium (Fragmin; Pfizer) as the first anticoagulant was approved by the US Fod and drug administration for use in paediatric patients older than one month to prevent symptomatic venous thromboembolism (VTE) caused by illnesses such congenital heart disease and cancer.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segments Covered

o By Type

o By Application

  • Regions Covered

o North America

o Europe

o Asia-Pacific

o Rest of the world

  • Competitive Landscape:Shenzhen Hepalink, Nanjing King-friend, Pfizer, SPL, Dongcheng Biochemicals among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Dalteparin Sodium Market by Segments

By Types,

  • Tablet
  • Injection

By Applications,

  • Myocardial Infarction Treatment
  • Hemodialysis
  • Others

Global  Dalteparin Sodium Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World

  • Latin America 
  • Middle East & Africa